Digital medicine company Akili Interactive is teaming up with Roblox to connect patients’ medical treatments to their favorite virtual worlds.
Through this partnership, Akili and Roblox are introducing new ways for medicine to fit into patients’ lives. Initially, the companies will establish an exclusive Roblox rewards exchange tied to Akili’s EndeavorRx treatment. The companies are exploring additional novel approaches and opportunities to engage Akili patients through Roblox integrations.
Why does it matter?
EndeavorRx is indicated to improve attention function as measured by computer-based testing in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Patients who engage with EndeavorRx demonstrate improvements in a digitally assessed measure Test of Variables of Attention (TOVA) of sustained and selective attention and may not display benefits in typical behavioral symptoms, such as hyperactivity. EndeavorRx should be considered for use as part of a therapeutic program that may include clinician-directed therapy, medication, and/or educational programs, which further address symptoms of the disorder.
EndeavorRx is available by prescription only. It is not intended to be used as a stand-alone therapeutic and is not a substitution for a child’s medication. EndeavorRx associated adverse events in clinical trials included frustration (6.1%), headache (1.3%), dizziness (0.6%), emotional reaction (0.4%), nausea (0.4%), and aggression (0.2%). No serious adverse events were associated with its use. EndeavorRx is recommended to be used for approximately 25 minutes a day, 5 days a week, over initially at least 4 consecutive weeks, or as recommended by your child’s health care provider. To learn more about EndeavorRx, please visit EndeavorRx.com.
On the record
“Roblox brings together tens of millions of people every day to connect, create, and express themselves, and we’re proud to be working with Akili to leverage that passion and enjoyment in connection with their first-in-class digital treatment,” said Craig Donato, Chief Business Officer of Roblox. “Akili has captured our imagination with its prescription treatment for children with ADHD delivered through an action video game experience and shares our vision and enthusiasm for what’s possible through interactive, digital experiences. We’re proud to help them as they lead the effort to realize new potential in the field of medicine.”
“We are committed to improving the world’s cognitive health through treatments that engage and wow patients,” said Eddie Martucci, CEO and Co-Founder of Akili Interactive. “Our FDA-cleared video game treatment demonstrates that medicine can be enjoyable, and that is only the beginning. Akili’s long-term vision aims to integrate digital medicine into patients’ daily lives in ways never before seen or experienced. Roblox has changed how millions learn, work, connect and play, and we are excited to work together to further push the boundaries of our industries and continue to redefine the experience of medicine.”
The context
Akili and Roblox are natural partners. Akili has challenged traditional perceptions of medicine and created EndeavorRx, the first and only prescription video game treatment for children with ADHD, cleared by the U.S. Food and Drug Administration (FDA). With more than 55 million people worldwide coming together on Roblox every day, Roblox is powering a platform for immersive, 3D shared experiences. Together, they have the ability to reimagine the patient experience.